loadpatents
name:-0.038992166519165
name:-0.061062097549438
name:-0.0013039112091064
Cavazza; Claudio Patent Filings

Cavazza; Claudio

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cavazza; Claudio.The latest application filed is for "therapeutical method for the treatment of the leber optic neuropathy".

Company Profile
0.57.33
  • Cavazza; Claudio - Rome IT
  • Cavazza; Claudio - Pomezia N/A IT
  • Cavazza; Claudio - Roma IT
  • Cavazza; Claudio - Pomezia RM
  • Cavazza; Claudio - 00144 Rome IT
  • Cavazza; Claudio - Chiasso CH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Therapeutical method for the treatment of the Leber optic neuropathy
Grant 9,114,120 - Cavazza , et al. August 25, 2
2015-08-25
Composition containing statins and omega-3 fatty acids
Grant 8,853,229 - Cavazza October 7, 2
2014-10-07
Therapeutical Method For The Treatment Of The Leber Optic Neuropathy
App 20140051757 - Cavazza; Claudio ;   et al.
2014-02-20
Long-term treatment of symptomatic heart failure
Grant 8,592,439 - Cavazza , et al. November 26, 2
2013-11-26
Combination Composition Useful For Treating Cardiovascular Diseases
App 20130236551 - Cavazza; Claudio
2013-09-12
Method useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance
Grant 8,389,574 - Cavazza , et al. March 5, 2
2013-03-05
Treatment Of Oncological Diseases
App 20120208883 - Cavazza; Claudio ;   et al.
2012-08-16
Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl L-carnitine and chitosan
Grant 8,198,260 - Cavazza June 12, 2
2012-06-12
Use Of Alkanoyl L-carnitine In Combination With Chemotherapeutic Agents For The Treatment Of Neoplasms
App 20120093809 - Cavazza; Claudio ;   et al.
2012-04-19
Long-term Treatment Of Symptomatic Heart Failure
App 20110178111 - Cavazza; Claudio ;   et al.
2011-07-21
Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents
Grant 7,897,641 - Cavazza March 1, 2
2011-03-01
Composition Useful For The Prevention Of Type 2 Diabetes And Its Complications In Pre-diabetic Patients With Insulin Resistance
App 20100048691 - Cavazza; Claudio ;   et al.
2010-02-25
Food supplemented with a carnitine, suitable for stimulating the biosynthesis of polyunsaturated fatty acids from the saturated fatty acids contained in the food
Grant 7,608,289 - Cavazza October 27, 2
2009-10-27
Composition for the prevention and treatment of kidney dysfunctions and diseases
Grant 7,585,896 - Cavazza September 8, 2
2009-09-08
Method for preventing and/or treating peripheral Neuropathies induced by the administration of an anticancer agent
App 20090143464 - Cavazza; Claudio ;   et al.
2009-06-04
Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
App 20090137619 - Cavazza; Claudio ;   et al.
2009-05-28
Package for at Least Two Different Products to be Sold and Used Together
App 20080272021 - Cavazza; Claudio
2008-11-06
Medicament for preventing and/or treating peripheral neuropathies
App 20080194683 - Cavazza; Claudio ;   et al.
2008-08-14
Composition Containing Statins and Omega-3 Fatty Acids
App 20080089876 - Cavazza; Claudio
2008-04-17
Medicament for preventing and/or treating peripheral neuropathies
App 20060258744 - Cavazza; Claudio ;   et al.
2006-11-16
Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
App 20060183798 - Cavazza; Claudio ;   et al.
2006-08-17
Food supplemented with a carnitine, suitable for stimulating the biosynthesis of polyunsaturated fatty acids from the saturated fatty acids contained in the food
Grant 6,932,999 - Cavazza August 23, 2
2005-08-23
Treating chronic uremic patients undergoing periodical dialysis
Grant 6,914,076 - Cavazza July 5, 2
2005-07-05
Food supplemented with a carnitine, suitable for stimulating the biosynthesis of polyunsaturated fatty acids from the saturated fatty acids contained in the food
App 20050100583 - Cavazza, Claudio
2005-05-12
Pharmaceutical compositions comprising alkanoyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism
App 20050026846 - Cavazza, Claudio
2005-02-03
Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl L-carnitine and chitosan
App 20050020538 - Cavazza, Claudio
2005-01-27
Composition for prevention and/or treatment of vascular diseases, comprising propionyl L-carnitine and coenzyme Q10
Grant 6,814,972 - Cavazza November 9, 2
2004-11-09
Composition comprising ketanserin AND AN ALKANOYL L-CARNITINE FOR THE TREATMENT OF CRPS
App 20040209906 - Cavazza, Claudio ;   et al.
2004-10-21
Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan
Grant 6,780,851 - Cavazza August 24, 2
2004-08-24
Combination composition in the form of nutritional supplement or pharmaceutical composition for the prevention and therapeutical treatment of degenerative or inflammatory articular disorders
Grant 6,761,898 - Cavazza July 13, 2
2004-07-13
Treating chronic uremic patients undergoing periodical dialysis
App 20040110836 - Cavazza, Claudio
2004-06-10
Composition for the prevention and treatment of kidney dysfunctions and diseases
App 20040057994 - Cavazza, Claudio
2004-03-25
Use of L carnitine and its alkanoyl dervatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy
Grant 6,696,492 - Cavazza , et al. February 24, 2
2004-02-24
Treating chronic uremic patients undergoing periodic dialysis
Grant 6,696,493 - Cavazza February 24, 2
2004-02-24
Composition for the prevention and treatment of kidney dysfunctions and diseases
Grant 6,653,349 - Cavazza November 25, 2
2003-11-25
Antioxidant composition comprising propionyl L-carnitine and a flavonoid against throm-bosis and atherosclerosis
App 20030206895 - Cavazza, Claudio
2003-11-06
Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of L-carnitine and extracts of ginkgo biloba
Grant 6,641,849 - Cavazza November 4, 2
2003-11-04
Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
App 20030199535 - Cavazza, Claudio ;   et al.
2003-10-23
Use of L-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
Grant 6,610,699 - Cavazza , et al. August 26, 2
2003-08-26
Composition for the prevention of muscle fatique and skeletal muscle adaptation of strenuous exercise
Grant 6,602,512 - Cavazza August 5, 2
2003-08-05
Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents
App 20030144354 - Cavazza, Claudio
2003-07-31
Composition for prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10
App 20030059418 - Cavazza, Claudio
2003-03-27
Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders
Grant 6,515,020 - Cavazza February 4, 2
2003-02-04
Medicament and therapeutical method for treating idiopathic asthenozoospermia
App 20030008921 - Cavazza, Claudio
2003-01-09
Treating chronic uremic patients undergoing periodical dialysis
App 20020198263 - Cavazza, Claudio
2002-12-26
Food supplemented with a carnitine, suitable for stimulating the biosynthesis of polyunaturated fatty acids from the saturated fatty acids contained in the food
App 20020192346 - Cavazza, Claudio
2002-12-19
Treating chronic uremic patients undergoing periodical dialysis
App 20020138032 - Cavazza, Claudio
2002-09-26
Treating chronic uremic patients undergoing periodical dialysis
Grant 6,429,230 - Cavazza August 6, 2
2002-08-06
Medicament and therapeutical method for treating idiopathic asthenozoospermia
App 20020058632 - Cavazza, Claudio
2002-05-16
Treating chronic uremic patients undergoing periodical dialysis
App 20020052415 - Cavazza, Claudio
2002-05-02
Antioxidant composition comprising acetyl L-carnitine and .alpha.-lipoic acid
Grant 6,365,622 - Cavazza April 2, 2
2002-04-02
Treating chronic uremic patients undergoing periodical dialysis
App 20020028850 - Cavazza, Claudio
2002-03-07
Method for treating celiac disease
Grant 6,348,495 - Cavazza , et al. February 19, 2
2002-02-19
Use of fumarate salt of L-carnitine or its alkanoyl derivatives in ischaemia
App 20020002202 - Cavazza, Claudio ;   et al.
2002-01-03
Composition comprising L-carnitine or an alkanoyl L-carnitine and long-chain alkanols
Grant 6,328,998 - Cavazza December 11, 2
2001-12-11
Use of L-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
App 20010044465 - Cavazza, Claudio ;   et al.
2001-11-22
Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
Grant 6,306,392 - Cavazza October 23, 2
2001-10-23
Medicament and therapeutical method for treating idiopathic asthenozoospermia
App 20010018455 - Cavazza, Claudio
2001-08-30
Nutritional supplement for facilitating skeletal muscle adaptation to strenuous exercise and counteracting defatigation in asthenic individuals
Grant 6,245,378 - Cavazza June 12, 2
2001-06-12
Medical food for diabetics
Grant 6,063,820 - Cavazza May 16, 2
2000-05-16
Therapeutical method for the treatment of attention-deficit/hyperactive disorders
Grant 5,869,528 - Cavazza February 9, 1
1999-02-09
Pharmaceutical composition comprising L-carnitine or an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders
Grant 5,753,703 - Cavazza , et al. May 19, 1
1998-05-19
Pharmaceutical composition comprising L-carnitine or derivative thereof and trihydroxy or tetrahydroxystilbene
Grant 5,747,536 - Cavazza May 5, 1
1998-05-05
Easters of acyl L-carnitines with gamma-hydroxybutyric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration and for the treatment of coma
Grant 5,534,549 - Tinti , et al. * July 9, 1
1996-07-09
Use of acetyl D-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment
Grant 5,432,199 - Cavazza July 11, 1
1995-07-11
Esters of L-carnitine and alkanoyl L-carnitines with glycolic acid or esters thereof and pharmaceutical compositions containing same for treating dermatoses
Grant 5,418,253 - Cavazza , et al. May 23, 1
1995-05-23
Alkanoyl L-carnitine amides with aminoacids and pharmaceutical compositions containing same for promoting regeneration of the nervous tissue, inhibiting neuronal degeneration, enhancing the process of learning and memory and for the treatment of coma
Grant 5,270,472 - Taglialatela , et al. December 14, 1
1993-12-14
Use of acetyl L-carnitine in the therapeutic treatment of coma
Grant 5,192,805 - Cavazza March 9, 1
1993-03-09
Use of L-carnitine derivatives in the therapeutical treatment of peripheral neuropathies
Grant 5,043,355 - Cavazza August 27, 1
1991-08-27
Use of acetyl l-carnitine in the therapeutic treatment of cataract, and pharmaceutical compositions useful in such treatment
Grant 5,037,851 - Cavazza August 6, 1
1991-08-06
Novel class of acyl-derivatives of carnitine, process for preparing same and therapeutic use thereof
Grant 4,859,698 - Cavazza , et al. August 22, 1
1989-08-22
Use of acetyl L-carnitine for the therapeutical treatment of shock conditions
Grant 4,771,075 - Cavazza September 13, 1
1988-09-13
Salts of-carnitine and alkanoyl L-carnitines and process for preparing same
Grant 4,602,039 - Cavazza July 22, 1
1986-07-22
Amides of acyl-carnitines, process for preparing same and pharmaceutical compositions containing such amides
Grant 4,443,475 - Cavazza April 17, 1
1984-04-17
Esters of acyl-carnitines, process for preparing same and pharmaceutical compositions containing such esters
Grant 4,439,438 - Cavazza March 27, 1
1984-03-27
Pharmaceutical composition comprising gamma-butyrobetaine for the treatment of syndromes induced by L-carnitine deficiency
Grant 4,382,092 - Cavazza May 3, 1
1983-05-03
Therapeutic method and compositions for the treatment of juvenile diabetes mellitus
Grant 4,362,719 - Cavazza December 7, 1
1982-12-07
Apparatus for mixing and dispersing two substances under sterile conditions
Grant 4,346,820 - Cavazza August 31, 1
1982-08-31
Pharmaceutical composition comprising an acyl-carnitine, for treating peripheral vascular diseases
Grant 4,343,816 - Cavazza August 10, 1
1982-08-10
Device for the quick inhalation of drugs in powder form by humans suffering from asthma
Grant 4,338,931 - Cavazza July 13, 1
1982-07-13
Method of treating abnormal lipoprote in ratios
Grant 4,255,449 - Cavazza March 10, 1
1981-03-10
Device for the extemporaneous preparation of a solution under sterile conditions
Grant 4,244,467 - Cavazza January 13, 1
1981-01-13
Device for containing a substance to be mixed with another substance in a vial
Grant 4,195,731 - Cavazza April 1, 1
1980-04-01
Therapeutic application of acetyl-d,l-carnitine and other acyl derivatives of d,l-carnitine
Grant 4,194,006 - Cavazza March 18, 1
1980-03-18
Pocket inhalator
Grant 4,130,116 - Cavazza December 19, 1
1978-12-19
Derivatives of nicotinic acid with amines variously substituted
Grant 4,021,436 - Cavazza May 3, 1
1977-05-03
Device, provided with a puncher and a dripper, for the hermetic sealing of containers
Grant 3,968,872 - Cavazza July 13, 1
1976-07-13
Company Registrations
SEC0001164803CAVAZZA CLAUDIO

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed